Maria G.
- Country
- Italy
- Department
- Department of Rheumatology
Research Overview
- Open-Label, Single-Arm 52‑Week Study of Subcutaneous Anifrolumab 120 mg Weekly in Immunosuppressant‑Naïve and Biologic‑Naïve Systemic Lupus Erythematosus Patients
- Long-Term Safety and Tolerability Assessment of Dapirolizumab Pegol in Patients with Systemic Lupus Erythematosus: A Multicenter, Open-Label Extension Study
- Evaluation of Dapirolizumab Pegol Efficacy and Safety in Moderately to Severely Active Systemic Lupus Erythematosus: A Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 86 of 163 partner sites.
Specializations
Autoimmune Disease Research
The investigator specializes in treating and studying systemic lupus erythematosus (SLE), with particular emphasis on evaluating novel therapeutic approaches for patients with moderate to severe disease manifestations.
- Active SLE Management
- Long-term Disease Control
- Treatment-resistant Cases
Key focus areas include assessment of disease activity patterns and therapeutic response in SLE patients.
Therapeutic Innovation
Actively involved in investigating emerging targeted immunological therapies for autoimmune conditions, including novel biological agents and small molecule treatments.
- Biological Therapeutics
- Immunomodulatory Treatments
- Standard-of-Care Enhancement
Expertise in evaluating combination approaches with standard-of-care medications for enhanced therapeutic outcomes.
Clinical Assessment
Specialized in measuring therapeutic efficacy through clinical response indicators and long-term safety monitoring in autoimmune conditions.
- Disease Activity Monitoring
- Treatment Safety Assessment
- Long-term Outcome Evaluation
Focuses on comprehensive patient assessment using validated disease activity measures and safety parameters.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.